>>My experience as an individual investor is that you have to work overtime to avoid the BIG loss.<<
Especially true in biotech. Hence the new tag line at the bottom of my iHub posts.
Mbkennel (whom we ought to get to post here) has some rules that are worth considering: Statistical issues --> Sell Regulatory issues --> Sell Management issues --> Sell
To these I would add another:
No SPA in pivotal trial --> Sell
There are exceptions, of course, and none of these rules should be applied dogmatically. But most of the time you will save money by following them.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”